Innovative "Bitter Blocker" Technology Could Help Improve Diets
SAN DIEGO, CA and ST. LOUIS, MO, September 15, 2008 /PRNewswire-FirstCall/
-- Senomyx, Inc. (Nasdaq: SNMX), a leading company focused on using
proprietary technologies to discover and develop novel flavor ingredients for
the food, beverage, and ingredient supply industries, and Solae, the leading
supplier of soy protein for food products, announced today they have reached
critical milestones in their collaboration to develop bitter blockers that
improve the taste of soy protein.
"We are excited about the progress we have made and look forward to the
end results and how we can help our customers and consumers," said Jon
McIntyre, Solae Vice President of Technology and Innovation. "After one year
of research and collaboration, we are making excellent progress, and our teams
are one step closer to identifying the systems that could help Solae enhance
the flavor profile of soy protein."
Food manufacturers use a variety of techniques to mask undesirable bitter
tastes, such as adding sugar, fat or salt to a recipe. The collaboration
between Senomyx and Solae aims to develop new bitter blockers that better
modulate and control bitterness in certain soy-based products. These
innovations could improve the nutritional value of foods by allowing
manufacturers to add more protein and use less sugar, salt and fat in their
products. The bitter taste blockers may also accelerate consumer acceptance of
nutritious foods containing soy protein.
"The rapid pace of our progress with the Solae bitter blocker program
underscores the value of Senomyx's proprietary technologies," added Mark
Zoller, Ph.D., Senomyx's Chief Scientific Officer and Executive Vice President
of Discovery and Development. "In relatively short order, we worked with
Solae's scientists and determined the components of soy protein responsible
for its bitterness, identified the bitter taste receptors activated by these
components, and discovered potential new ingredients that modulate the
receptor response in our assay. We are very pleased with the accomplishments
being made by the Senomyx Bitter Blocker team in collaboration with our Solae
In April 2007, Senomyx and Solae entered into a collaborative agreement
for the discovery, development and commercialization of novel flavor
ingredients intended to enhance the taste characteristics of soy proteins.
Solae Vice President of New Business Development Miguel Angelo de Oliveira
noted the Solae-Senomyx partnership will drive new innovation opportunities
for Solae and its customers.
"The partnership with Senomyx will yield significant opportunities to
enhance and advance soy protein's profile and role in food products," Oliveira
said. "This partnership is one of the many new business and technology
initiatives that Solae anticipates embarking on in the coming years. We are
dedicated to advancing global nutrition through food ingredient innovation."
Soy protein is used in a wide variety of products, including energy bars,
breakfast cereals, infant formula and beverages. As consumer demand for
healthier food options increases, food manufacturers are increasingly looking
to formulate products with soy protein. The companies expect to develop novel
soy protein flavor enhancers and taste modulators using Senomyx's proprietary
taste receptor-based assays and screening technologies.
"The advances being made in Senomyx's collaboration with Solae are an
indication of the potential benefits that Senomyx can bring to our partner
companies," stated Kent Snyder, President, Chief Executive Officer, and
Chairman of the Board of Senomyx. "Our programs are intended to develop flavor
ingredients that reduce bitterness, sugar, and salt without compromising
taste, allowing our partners to provide new choices for consumers seeking
tasteful products with improved nutritional profiles."
Under the licensing agreement, Solae will have exclusive worldwide use of
the flavor ingredients in virtually all categories of foods and beverages that
contain added soy protein. Solae will fund the discovery and development of
these flavor systems, and Senomyx will be entitled to certain milestone and
royalty payments based on sales of Solae products containing any flavor
ingredients developed under the agreement.
About Senomyx, Inc.
Senomyx is a leading company using proprietary taste receptor technologies
to discover and develop novel flavor ingredients in the savory, sweet, salt,
bitter, and cooling areas. Senomyx has entered into product discovery and
development collaborations with seven of the world's foremost food, beverage,
and ingredient supply companies: Ajinomoto Co., Inc., Cadbury plc, Campbell
Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae.
Nestle is currently marketing products that contain one of Senomyx's flavor
ingredients. For more information, please visit http://www.senomyx.com.
Solae, LLC is the global leader in the research, development and
manufacture of soy protein ingredients. Headquartered in St. Louis, Missouri,
USA, with annual revenue exceeding $1 billion, the company is a joint venture
between DuPont and Bunge Limited. For more information, visit
Statements contained in this press release regarding matters that are not
historical facts are "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Because such statements are
subject to risks and uncertainties, actual results may differ materially from
those expressed or implied by such forward-looking statements. Such statements
include, but are not limited to, statements regarding: the capabilities of
Senomyx's flavor ingredients; Senomyx's ability to discover new flavor
ingredients; and Senomyx's ability, or Senomyx's collaborators' ability, to
commercialize products incorporating Senomyx's flavor ingredients in packaged
foods and beverages. Risks that contribute to the uncertain nature of the
forward-looking statements include: Senomyx is dependent on its product
discovery and development collaborators for all of Senomyx's revenue; Senomyx
is dependent on its current and any future product discovery and development
collaborators to develop and commercialize any flavor ingredients Senomyx may
discover; Senomyx may be unable to develop flavor ingredients useful for
formulation into products; Senomyx or its collaborators may be unable to
obtain and maintain the regulatory approval required for flavor ingredients to
be incorporated into products that are sold; even if Senomyx or its
collaborators receive a regulatory approval and incorporate Senomyx flavor
ingredients into products, those products may never be commercially
successful; and Senomyx's ability to compete in the flavor ingredients market
may decline if Senomyx does not adequately protect its proprietary
technologies. These and other risks and uncertainties are described more fully
in Senomyx's most recently filed SEC documents, including its Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, under the headings "Risks Related
to Our Business" and "Risks Related to Our Industry." All forward-looking
statements contained in this press release speak only as of the date on which
they were made. Senomyx undertakes no obligation to update such statements to
reflect events that occur or circumstances that exist after the date on which
they were made.
Vice President, Investor Relations & Corporate Communications
Senior Manager, Global Communications
SOURCE Senomyx, Inc.